Seattle biotech Dendreon files for bankruptcy, considers sale - Geek...

11/10/14

Seattle biotech Dendreon files for bankruptcy, considers sale
GeekWire
Dendreon, a once-promising Seattle biotech company developing treatments for prostate cancer, today filed for Chapter 11 bankruptcy protection. It marks the latest in a tough saga for a company that held extreme promise, but could not gain sales ...

[more]